版本:
中国

BRIEF-Aerie Pharmaceuticals raises $125 million in public offerings

Sept 16 Aerie Pharmaceuticals :

* Aerie Pharmaceuticals raises $125 million in public offerings

* Intends to use net proceeds for complete funding of rhopressa(tm)commercialization costs, execution of clinical trials in Japan

* Also intends to use proceeds for construction of a manufacturing plant in Ireland,continuation of preclinical activity in support of its product pipeline

* Aerie Pharmaceuticals Inc says offering was upsized by $25 million over offering amount anticipated to be sold as previously announced

* This is in addition to $50 million raised separately through completion and full utilization of an ATM program with Cantor Fitzgerald

* Aerie Pharmaceuticals inc says shares sold through $50 million ATM program will be issued on or about September 20, 2016 Source text for Eikon: Further company coverage: [ ]

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐